AROS PHARMA ApS: Financial statements 2012
CVR: 32102816
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
AROS PHARMA ApS (CVR 32102816) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -3,245,679. Equity in the 2012 report amounted to DKK 4,156,121. The solvency ratio was 88.1%.
- Profit/Loss
- DKK -3,245,679
- Equity
- DKK 4,156,121
- Total Assets
- DKK 4,718,592
Keep an eye on AROS PHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 15, 2012, Martin Bonde has left the board of directors of AROS PHARMA ApS.
As of March 26, 2012, JUT NR. 2180 A/S has been appointed auditor of AROS PHARMA ApS.
As of March 26, 2012, EY Danmark A/S has stepped down as auditor of AROS PHARMA ApS.
About AROS PHARMA ApS
AROS PHARMA ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2009 and dissolved in 2016. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company has 0 employees (2015). In 2015, the company reported a net result of DKK -721,837 compared with DKK -2,904,493 the year before. Equity in the 2015 report amounted to DKK -3,371,172.